Library

Reading List

CSA311 - Clinical Pharmacokinetics 3

New Reading Lists System

The University has a new and improved reading lists system.

Please use the new Reading Lists for all units after Semester 2, 2020
e.g Spring & Summer School, Term 4, ASP.

NEW CSA311 Reading List

New Reading List Home

*All reading lists will be available from the new system from the 14th December, 2020

CSA311 - Clinical Pharmacokinetics 3

Offered By: Health Science

Lecturer: Dr Barbara Wimmer

Unit Code: CSA311

Unit Info

Key
PDF Utas Catalogue Other
DOC Web Link

https://onlinelibrary-wiley-com.ezproxy.utas.edu.au/doi/abs/10.1111/jcpt.12646 Alatawi, Y. et al, 2018, 'Brand vs generic adverse event reporting patterns : an authorized generic-controlled evaluation of cardiovascular medications', Journal of clinical pharmacy and therapeutics, 43, 3, 327-335

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997304/ Bailey, D. G., 2010, 'Fruit juice inhibition of uptake transport: a new type of food-drug interaction', British journal of pharmacology, 70, 5, 645-655

https://www.nps.org.au/australian-prescriber/articles/generics-equal-or-not Birkett, D. J., 2003, 'Generics : equal or not?', Australian prescriber, 26, 4, 85-87

CSA311-0009-9236-2010-88-6.pdf Boylan, L. S., 2010, 'Following the money in epilepsy therapeutics', Clinical pharmacology and therapeutics, 88, 763

https://www-sciencedirect-com.ezproxy.utas.edu.au/science/article/pii/S0376871603000589 Chiang, C. N., Hawks, R. L., 2003, 'Pharmacokinetics of the combination tablet of buprenorphine and naloxone', Drug and alcohol dependence, 70, 2, S39-S47

CSA311-1532-6535-2012-92-5.pdf Dolton, M. J., Roufogalis, B. D., McLachlan, A. J., 2012, 'Fruit juices as perpetrators of drug interactions : the role of organic anion-transporting polypeptides', Clinical pharmacology & therapeutics CPT, 92, 622-630

http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104631308&site=ehost-live Durand, C., Alhammad, A., Willett, K. C., 2012, 'Practical considerations for optimal transdermal drug delivery', American journal of health-system pharmacy, 69, 2, 116-124

http://ezproxy.utas.edu.au/login?url=http://ovidsp.ovid.com.ezproxy.utas.edu.au/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006842-201301000-00014&LSLINK=80&D=ovft Faasse, K. et al., 2013, 'The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects', Psychosomatic medicine, 75, 1, 90-96

https://www-bmj-com.ezproxy.utas.edu.au/content/339/bmj.b5613 Faasse, K., Cundy, T., Petrie, K., 2009, 'Thyroxine : anatomy of a health scare', British medical journal, 339, b5613

CSA311-313 1085-8733 v58n3.pdf Gertz, B. J. et al., 1995, 'Studies of the oral bioavailability of alendronate', Clinical pharmacology & therapeutics, 58, 288-298

https://www-ncbi-nlm-nih-gov.ezproxy.utas.edu.au/pmc/articles/PMC4859299/ Jackeviciu, C. A. et al., 2016, 'Comparative effectiveness of generic atorvastatin and Lipitor® in patients hospitalized with an acute coronary syndrome', Journal of the American Heart Association, 5, 4, 1-13, 1-5

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425062/?report=classic Jain, R. T., Panda, J., Srivastava, A., 2011, 'Two formulations of venlafaxine are bioequivalent when administered as open capsule mixed with applesauce to healthy subjects', Indian journal of pharmaceutical sciences, 73, 5, 510-516

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04324.x/full Jeon, H. et al., 2013, 'Apple juice greatly reduces systemic exposure to atenolol', British journal of clinical pharmacology, 75, 1, 172-179

https://jamanetwork-com.ezproxy.utas.edu.au/journals/jama/fullarticle/1028758 Kesselheim, A. S., 2008, 'Clinical equivalence of generic and brand-name drugs used in cardiovascular disease : a systematic review and meta-analysis', JAMA, 300, 21, 2514-2526

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650585/ Krishna, G. et al., 2009, 'Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers', Antimicrobial agents and chemotherapy, 53, 3, 958-966

http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2003.01893.x/abstract Labiris, N. R., Dolovich, M. B., 2003, 'Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications', British journal of clinical pharmacology, 56, 6, 600-612

http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2003.01892.x/abstract Labiris, N. R., Dolovich, M. B., 2003, 'Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications', British journal of clinical pharmacology, 56, 6, 588-599

https://doi.org/10.18773/austprescr.2007.021 McLachlan, A. J., Ramzan, I., Milne, R. W., 2007, 'Frequently asked questions about generic medicines', Australian prescriber, 30, 2, 41-43

https://www.nps.org.au/australian-prescriber/articles/meals-and-medicines McLachlan, A., Ramzan, I., 2006, 'Meals and medicines', Australian prescriber, 29, 2, 40-42

http://onlinelibrary.wiley.com.ezproxy.utas.edu.au/doi/10.1111/bcp.13076/full Mielke, J. et al., 2016, 'Clinical trials for authorized biosimilars in the European Union : a systematic review', British journal of clinical pharmacology, 82, 6, 1444-1457

http://onlinelibrary.wiley.com/doi/10.1111/bcp.12628/full Moore, R. A. et al., 2015, 'Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs : a systematic review', British journal of clinical pharmacology, 80, 3, 381-388

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867568/ Naylor, H. et al., 2013, 'Decreased tacrolimus levels after administration of rifampin to a patient with renal transplant', Canadian journal of hospital pharmacy , 66, 6, 388–392

CSA311-0009-9236-2010-88-4.pdf Osterberg, L. G., Urquhart, J., Blaschke, T. F., 2010, 'Understanding forgiveness : minding and mining the gaps between pharmacokinetics and therapeutics', Clinical pharmacology and therapeutics, 88, 457-459

https://onlinelibrary-wiley-com.ezproxy.utas.edu.au/doi/10.1002/jppr2004343195 Pearce, G. A., McLachlan, A. J., Ramzan, I., 2004, 'Bioequivalence : how, why, and what does it really mean?', Journal of pharmacy practice and research, 34, 3, 195-200

http://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=17996311&site=ehost-live Prausnitz, M. R., Mitragotri, S., Lanfer, R., 2004, 'Current status and future potential of transdermal drug delivery', Nature reviews. Drug discovery, 3, 2, 115-124

https://link-springer-com.ezproxy.utas.edu.au/article/10.1007/s00228-008-0579-2 Queckenberg, C., Fuhr, U., 2009, 'Influence of posture on pharmacokinetics', European journal of clinical pharmacology, 65, 2, 109-119

https://www.researchgate.net/publication/11223537_Enterohepatic_circulation_Physiological_pharmacokinetic_and_clinical_implications Roberts M. et al., 2002, 'Enterohepatic circulation : physiological, pharmacokinetic and clinical implications', Clinical pharmacokinetics, 41, 10, 751-790

https://www-ncbi-nlm-nih-gov.ezproxy.utas.edu.au/pmc/articles/PMC1364588/ Rolan, P. E., 1994, 'Plasma protein binding displacement interactions : why are they still regarded as clinically important?', British journal of clinical pharmacology, 37, 2, 125-128

https://journals-sagepub-com.ezproxy.utas.edu.au/doi/abs/10.1345/aph.1A208 Sands, C. D., Chan, E. S., Welty, T. E., 2002, 'Revisiting the significance of warfarin protein-binding displacement interactions', Annals of pharmacotherapy, 36, 10, 1642-1644

https://www.nps.org.au/australian-prescriber/articles/oral-extended-release-products Sansom, L. N., 1999, 'Oral extended-release products', Australian prescriber, 22, 88-90

http://www.sciencedirect.com.ezproxy.utas.edu.au/science/article/pii/S1045105610001144 Skrilin, A. et al. , 2010, 'Comparison of the physicochemical properties of a biosimilar filgrastim with those of reference filgrastim', Biologicals, 38, 5, 557-566

http://pubs.acs.org.ezproxy.utas.edu.au/doi/abs/10.1021/acs.jmedchem.5b00201 Smith, D. A. et al., 2015, 'Volume of distribution in drug design', Journal of medicinal chemistry, 58, 15, 5691−5698

https://link.gale.com/apps/doc/A199858521/AONE?u=utas1&sid=AONE&xid=eb04633a Staatz, C. E., Teft, S. E., 2007, 'Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients', Clinical pharmacokinetics, 46, 1, 13-58

http://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=15910045&site=ehost-live Torchilin, V. P., 2005, 'Recent advances with liposomes as pharmaceutical carriers', Nature reviews. Drug discovery, 4, 2, 145-160

https://go-gale-com.ezproxy.utas.edu.au/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=1&docId=GALE%7CA439834179&docType=Report&sort=Relevance&contentSegment=ZONE-MOD1&prodId=AONE&contentSet=GALE%7CA439834179&searchId=R1&userGroupName=utas1&inPS=true&ps=1&cp=1 Udpa, N., Million, R. P. , 2016, 'Monoclonal antibody biosimilars', Nature reviews. Drug discovery, 15, 1, 13-14

https://doi.org/10.1016/j.biopha.2018.10.078 Waghule, T. et al., 2019, 'Microneedles : a smart approach and increasing potential for transdermal drug delivery system', Biomedicine & pharmacotherapy, 109, January, 1249-1258

https://link-springer-com.ezproxy.utas.edu.au/article/10.1007/s00277-010-0961-x Waller, C. F. et al., 2010, 'Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim : results from a randomized, phase I trial', Annals of hematology, 89, 9, 927-933

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924967/ Waller, C. F. et al., 2010, 'Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim : results from a randomized, phase I trial', Annals of hematology, 89, 10, 971–978

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466398/ Won, C. S., Oberlies, N. H., Paine, M. F., 2012, 'Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport', Pharmacology & therapeutics, 136, 2, 186-201